LobbyingHealthcare Distribution Alliance lobbying by quarter
Healthcare Distribution Alliance's latest lobbying report covers Q2 2026, at $567.9K. The four quarters Q4 2025–Q3 2026 total $1.7M. Its first report covers Q4 2022; the issues it reports most are Health Issues and Pharmacy.
Healthcare Distribution Alliance
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $1.7M
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $554.9K | 1 |
| Q1 2023 | $656.4K | 1 |
| Q2 2023 | $573.1K | 1 |
| Q3 2023 | $573K | 1 |
| Q4 2023 | $604.6K | 1 |
| Q1 2024 | $540.7K | 1 |
| Q2 2024 | $518.5K | 1 |
| Q3 2024 | $497.5K | 1 |
| Q4 2024 | $511.1K | 1 |
| Q1 2025 | $509K | 1 |
| Q2 2025 | $515.8K | 1 |
| Q3 2025 | $555.3K | 1 |
| Q4 2025 | $596.6K | 1 |
| Q1 2026 | $545.4K | 1 |
| Q2 2026 | $567.9K | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$3.9M · 15 reports
- Pharmacy$3.9M · 15 reports
- Taxation$341.6K · 2 reports
- Budget and appropriations$185K · 1 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- Drug Enforcement Administration (DEA)15 reports
- Food & Drug Administration (FDA)15 reports
- Health & Human Services, Dept of (HHS)15 reports
- HOUSE OF REPRESENTATIVES15 reports
- SENATE15 reports
- White House Office14 reports
- Centers For Medicare and Medicaid Services (CMS)5 reports
Firms it paid
| Firm | ||
|---|---|---|
| In-houseHealthcare Distribution Alliance | $8.3M | 15 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| KIRSTEN FOSTER | Professional Staff Member - Senate Finance Committee February 2019-March 2020, Legislative Director Rep. David B. McKinley March 2020-December 2021 | Q2 2023 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/16for Q2 | In-house | $567.9K |
| 04/16for Q1 | In-house | $545.4K |
| 01/15for Q4 2025 | In-house | $596.6K |
| 25/10/16for Q3 2025 | In-house | $555.3K |
| 25/07/14for Q2 2025 | In-house | $515.8K |
| 25/04/16for Q1 2025 | In-house | $509K |
| 25/01/15for Q4 2024 | In-house | $511.1K |
| 24/10/16for Q3 2024 | In-house | $497.5K |
| 24/07/17for Q2 2024 | In-house | $518.5K |
| 24/04/19for Q1 2024 | In-house | $540.7K |
| 24/01/18for Q4 2023 | In-house | $604.6K |
| 23/10/19for Q3 2023 | In-house | $573K |
| 23/07/20for Q2 2023 | In-house | $573.1K |
| 23/04/20for Q1 2023 | In-house | $656.4K |
| 23/01/19for Q4 2022 | In-house | $554.9K |